|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.618 EUR | -0.98% |
|
-2.68% | -29.59% |
| 03-24 | Has Valneva Been Oversold? |  |
| 03-23 | Health Care Up, but Not by Much, Amid Cyclical Rotation -- Health Care Roundup | DJ |
Company Valuation: Valneva SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 2,574 | 861.1 | 655.1 | 351.1 | 642.3 | 454.9 | - | - |
| Change | - | -66.55% | -23.93% | -46.4% | 82.94% | -29.18% | - | - |
| Enterprise Value (EV) 1 | 2,286 | 670.5 | 737.8 | 399.1 | 642.3 | 578.3 | 504.9 | 451.5 |
| Change | - | -70.66% | 10.04% | -45.9% | 60.92% | -9.97% | -12.69% | -10.59% |
| P/E ratio | -32.7x | -5.02x | -6.47x | -27x | -5.47x | -7.08x | 5.62x | 13.1x |
| PBR | 15.1x | - | 5.1x | 1.94x | - | 10.3x | 3.36x | 2.91x |
| PEG | - | -0.1x | 0.2x | 0.3x | -0x | 0.2x | -0x | -0.2x |
| Capitalization / Revenue | 7.4x | 2.38x | 4.26x | 2.07x | 3.68x | 2.75x | 1.43x | 1.7x |
| EV / Revenue | 6.57x | 1.86x | 4.8x | 2.35x | 3.68x | 3.5x | 1.59x | 1.69x |
| EV / EBITDA | -48.5x | -9.69x | -11.3x | 12.1x | -10.8x | -17.9x | 4.89x | 12.4x |
| EV / EBIT | -37.2x | -5.91x | -8.99x | 29.9x | -7.91x | -10.9x | 6.31x | 10.5x |
| EV / FCF | -140x | -2.44x | -3.4x | -4.92x | - | -10.1x | 6.98x | -109x |
| FCF Yield | -0.71% | -41% | -29.4% | -20.3% | - | -9.93% | 14.3% | -0.92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.75 | -1.24 | -0.73 | -0.08 | -0.68 | -0.3699 | 0.4655 | 0.2 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 348.1 | 361.3 | 153.7 | 169.6 | 174.7 | 165.2 | 317.6 | 267.5 |
| EBITDA 1 | -47.1 | -69.2 | -65.24 | 32.92 | -59.42 | -32.33 | 103.3 | 36.49 |
| EBIT 1 | -61.4 | -113.4 | -82.09 | 13.33 | -81.16 | -53.2 | 80.02 | 43.14 |
| Net income 1 | -73.4 | -143.3 | -101.4 | -12.25 | -115.2 | -63.72 | 73.55 | 35.83 |
| Net Debt 1 | -288.9 | -190.6 | 82.74 | 48.04 | - | 123.4 | 50.06 | -3.399 |
| Reference price 2 | 24.500 | 6.224 | 4.720 | 2.162 | 3.718 | 2.618 | 2.618 | 2.618 |
| Nbr of stocks (in thousands) | 105,078 | 138,355 | 138,788 | 162,397 | 172,759 | 173,753 | - | - |
| Announcement Date | 03/02/22 | 23/03/23 | 21/03/24 | 20/03/25 | 17/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.15x | 3.53x | -18.03x | -.--% | 542M | |
| 32.23x | 5.62x | 17.42x | 1.02% | 47.33B | |
| 56.03x | 4.84x | 32.53x | -.--% | 34.38B | |
| 21.57x | 2.46x | 10.6x | -.--% | 29.42B | |
| 33.19x | 8.17x | 21.02x | 0.38% | 28.39B | |
| -18.87x | 512.08x | -17.31x | -.--% | 29.13B | |
| 50.52x | 9.04x | 28.29x | -.--% | 15.44B | |
| 30.39x | 4.93x | 22.45x | -.--% | 14.85B | |
| 23.07x | 2.01x | 8.83x | 1.1% | 14.22B | |
| Average | 24.55x | 61.41x | 11.76x | 0.28% | 23.74B | |
| Weighted average by Cap. | 28.23x | 74.40x | 15.13x | 0.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- VLA Stock
- Valuation Valneva SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition